We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Holds Back Approval of Teva’s Generic Lovenox
FDA Holds Back Approval of Teva’s Generic Lovenox
February 2, 2011
The FDA has dealt Teva Pharmaceutical Industries a setback in its effort to win approval of a generic version of Sanofi-Aventis’ blood thinner Lovenox, telling the company it needs more information before it can approve its application.